Gary L. Norman
Research Subjects
Gary L. Norman has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Zakera Shums
INOVA Diagnostics, Inc., 9900 Old Grove Road, San Diego, CA 92131-1638, USA
8 shared publications - Eduardo Mauriño
Small Intestine Section, Department of Medicine, Hospital de Gastroenterología “Dr. Carlos Bonorino Udaondo”, Buenos Aires, Argentina
3 shared publications - Jay L. Milo
Inova Diagnostics, Division of Research, San Diego, CA, USA
3 shared publications Julio C. Bai
3 shared publicationsMaría Laura Moreno
3 shared publicationsAndrea F. Gonzalez
2 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1036 - Prevalence of Primary Biliary Cholangitis-Related Autoantibodies in Patients with Celiac Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1036 - Prevalence of Primary Biliary Cholangitis-Related Autoantibodies in Patients with Celiac Disease
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S266-S267
The Combination of Serum I-Fabp and Specific Serology are Highly Predictive Non-Invasive Diagnostic Tools for Celiac Disease in High Pre-Test Populations
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S266-S267
The Combination of Serum I-Fabp and Specific Serology are Highly Predictive Non-Invasive Diagnostic Tools for Celiac Disease in High Pre-Test Populations
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S685
Mo1274 Serum I-FABP and Serology in the Follow-Up of Celiac Disease Patients. A Prospective 1-Year Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S685
Mo1274 Serum I-FABP and Serology in the Follow-Up of Celiac Disease Patients. A Prospective 1-Year Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S890
Tu1382 Correlation of Celiac Serologies and Intestinal Fatty Acid-Binding Protein with Marsh Score and Quantitative Histology
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S890
Tu1382 Correlation of Celiac Serologies and Intestinal Fatty Acid-Binding Protein with Marsh Score and Quantitative Histology
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S566
Su1836 Significance of Serological Markers in the Disease Course of Ulcerative Colitis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S566
Su1836 Significance of Serological Markers in the Disease Course of Ulcerative Colitis
- 12 February 2012
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 22 (6) , 892-898
High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis
Objective To investigate the prevalence of primary biliary cirrhosis (PBC) and PBC-associated autoantibodies in Japanese systemic sclerosis (SSc) patients. Methods Clinical data from 225 Japanese SSc patients were retrospectively obtained. Serum samples from these patients were examined for PBC-associated autoantibodies, anti-mitochondrial M2 antibodies (AMA), anti-sp100 antibodies (anti-sp100), and anti-gp210 antibodies (anti-gp210) by enzyme-linked immunosorbent assay. Results Of 225 patients, 37 (16.4%) had AMA, 13 (5.8%) had anti-sp100, and 3 (1.3%) had anti-gp210. Three patients were positive for both AMA and anti-sp100, and 2 were positive for both AMA and anti-gp210. PBC was found in 22 (9.8%) patients positive for AMA with or without anti-sp100 or anti-gp210, but not in those with anti-sp100 or anti-gp210 without AMA. Furthermore, 13 patients lacking these three antibodies were diagnosed with or suspected of PBC by liver biopsy and/or their clinical manifestation. Multivariable analysis revealed that AMA and anti-centromere antibodies were independently associated with PBC in SSc patients, while anti-sp100 and anti-gp210 were not. Conclusions This study has demonstrated even higher prevalence of both PBC-associated autoantibodies and PBC in the Japanese SSc population than in the Caucasian SSc population. AMA and anti-centromere antibodies are likely to indicate increasing risk of PBC in SSc patients.
- 12 February 2012
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 22 (6) , 892-898
High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis
Objective To investigate the prevalence of primary biliary cirrhosis (PBC) and PBC-associated autoantibodies in Japanese systemic sclerosis (SSc) patients. Methods Clinical data from 225 Japanese SSc patients were retrospectively obtained. Serum samples from these patients were examined for PBC-associated autoantibodies, anti-mitochondrial M2 antibodies (AMA), anti-sp100 antibodies (anti-sp100), and anti-gp210 antibodies (anti-gp210) by enzyme-linked immunosorbent assay. Results Of 225 patients, 37 (16.4%) had AMA, 13 (5.8%) had anti-sp100, and 3 (1.3%) had anti-gp210. Three patients were positive for both AMA and anti-sp100, and 2 were positive for both AMA and anti-gp210. PBC was found in 22 (9.8%) patients positive for AMA with or without anti-sp100 or anti-gp210, but not in those with anti-sp100 or anti-gp210 without AMA. Furthermore, 13 patients lacking these three antibodies were diagnosed with or suspected of PBC by liver biopsy and/or their clinical manifestation. Multivariable analysis revealed that AMA and anti-centromere antibodies were independently associated with PBC in SSc patients, while anti-sp100 and anti-gp210 were not. Conclusions This study has demonstrated even higher prevalence of both PBC-associated autoantibodies and PBC in the Japanese SSc population than in the Caucasian SSc population. AMA and anti-centromere antibodies are likely to indicate increasing risk of PBC in SSc patients.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Pr3-ANCA in Inflammatory Bowel Disease: A Useful Marker to Differentiate Ulcerative Colitis From Crohn's Disease?
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Pr3-ANCA in Inflammatory Bowel Disease: A Useful Marker to Differentiate Ulcerative Colitis From Crohn's Disease?
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4) , A-478-478
T1077 Occurrence of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Body Gastritis Patients with or Without Pernicious Anemia
- 30 April 2008
- Published by Elsevier in Gastroenterology
- Vol. 134 (4) , A-478-478
T1077 Occurrence of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Body Gastritis Patients with or Without Pernicious Anemia